Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies

ROCKVILLE, Md. — November 11, 2021 — Psomagen, Inc., a North American sequencing-based contract laboratory service and data analysis provider with both CLIA-certified and CAP-accredited facilities, has partnered with Olink Proteomics, which offers an innovative DNA-coupled immunoassay that identifies and quantifies protein biomarkers in clinical samples. The partnership enables end-to-end multi-omics clinical studies, a step […]